SARS-CoV-2:当前对抗COVID-19的工具ST-升高心肌梗塞
Syed Ifthikar1, Javad Savoj1, Harjeet Singh2
1Cardiology, HCA Healthcare Riverside, Riverside, USA.
Cureus
|September 18, 2023
概括
严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 导致致命的炎症和凝血问题. 一些患有ST升高心肌梗塞 (ST-elevation myocardial infarction,STEMI) 的COVID-19患者会发生严重的,无法治疗的心上血栓形成,导致高死亡率.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 病理学 病理学 病理学
背景情况:
- 严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2) 显著影响炎症和凝血通路,导致全球死亡率.
- 由SARS-CoV-2引起的细胞因子风暴与心血管疾病中的微血管血栓症有关.
- 一部分COVID-19患者呈现ST升高心肌梗塞 (STEMI) 和严重心表血栓形成.
研究的目的:
- 介绍一系列COVID-19阳性患者的病例,这些患者经历了STEMI与耐火性心上血栓.
- 为了突出传统的STEMI疗法的局限性,在这个特定的患者群体.
- 探索潜在的替代治疗策略,以改善治疗结果.
主要方法:
- 对COVID-19阳性STEMI患者的回顾性分析,这些患者血管学证实了心上表皮血栓.
- 对传统的STEMI疗法进行审查,包括冠状动脉再血管化.
- 记录患者的治疗结果和死亡率.
主要成果:
- 所有分析的患者都出现了STEMI和严重的心表血栓.
- 确定的血栓对传统的STEMI治疗不耐药.
- 在这个案例系列中,死亡率高达90%.
结论:
- 与COVID-19相关的STEMI与耐火性心上血栓形成有极高的死亡风险.
- 在这些情况下,传统的STEMI疗法往往是无效的.
- 研究机械血栓切除术,优化抗凝剂和早期血液动力学支持等新方法对于潜在地提高生存率至关重要.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
01:28Acute Coronary Syndrome IV: Interprofessional Care
11
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
01:27Coronary Artery Disease V: Interprofessional Care
9
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
01:14Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
01:30Acute Coronary Syndrome III: Diagnostic Studies
9
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9
01:26Coronary Artery Disease IV: Preventive Measures
23
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
23